Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B EBIT

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B (BDXB) currently reports a EBIT of $2.1B as of June 2026. That compares with $2.5B in the prior-year period — down 15.8% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's EBIT history and peer comparisons.

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's EBIT decreased from $2.5B to $2.1B — a 15.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's EBIT of $2.1B is lower than the Healthcare sector average of $23B. That is roughly 90.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B reported $2.1B in EBIT as of June 2026. That compares with $2.5B in the prior-year period — down 15.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $2.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B, and consider following BDXB for alerts when major investors trade the stock.